Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1999-2-3
|
pubmed:abstractText |
HLA-DR antigens a side from their antigen-presenting function have recently been shown to allow for transmembrane signaling. Findings in several models suggest that such a signaling function may occur in hematopoietic tissues. Signals generated via HLA-DR result in upregulation of tumor necrosis factor alpha (TNF-alpha) and nitric oxide as well as an enhanced expression of Fas and its natural ligand (Fas-L), all molecules associated with programmed cell death (apoptosis). While a role of HLA-DR in hematopoietic failure remains hypothetical, the data presented here can be accommodated into a model of hematopoietic failure initiated by HLA-DR mediated signals.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0004-069X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
285-91
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9832067-Animals,
pubmed-meshheading:9832067-HLA-DR Antigens,
pubmed-meshheading:9832067-Hematopoiesis,
pubmed-meshheading:9832067-Humans,
pubmed-meshheading:9832067-Nitric Oxide,
pubmed-meshheading:9832067-Signal Transduction,
pubmed-meshheading:9832067-Tumor Necrosis Factor-alpha
|
pubmed:year |
1998
|
pubmed:articleTitle |
MHC class II and negative regulators of hematopoiesis.
|
pubmed:affiliation |
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Review
|